Fidelity Investments’s Viking Therapeutics VKTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$260M Sell
9,821,897
-1,427,440
-13% -$37.8M 0.01% 720
2025
Q1
$272M Sell
11,249,337
-5,466,101
-33% -$132M 0.02% 681
2024
Q4
$673M Buy
16,715,438
+96,008
+0.6% +$3.86M 0.04% 367
2024
Q3
$1.05B Buy
16,619,430
+79,149
+0.5% +$5.01M 0.06% 254
2024
Q2
$877M Buy
16,540,281
+192,989
+1% +$10.2M 0.06% 276
2024
Q1
$1.34B Buy
16,347,292
+1,342,952
+9% +$110M 0.09% 188
2023
Q4
$279M Buy
15,004,340
+16
+0% +$298 0.02% 621
2023
Q3
$166M Buy
15,004,324
+28,517
+0.2% +$316K 0.01% 776
2023
Q2
$243M Buy
14,975,807
+4,053,059
+37% +$65.7M 0.02% 650
2023
Q1
$182M Buy
10,922,748
+10,920,979
+617,353% +$182M 0.02% 748
2022
Q4
$16.6K Sell
1,769
-298
-14% -$2.8K ﹤0.01% 3840
2022
Q3
$6K Sell
2,067
-31
-1% -$90 ﹤0.01% 4275
2022
Q2
$6K Buy
2,098
+670
+47% +$1.92K ﹤0.01% 4281
2022
Q1
$4K Buy
1,428
+1,358
+1,940% +$3.8K ﹤0.01% 4523
2021
Q4
$0 Buy
70
+11
+19% ﹤0.01% 4981
2021
Q3
$0 Sell
59
-136
-70% ﹤0.01% 5095
2021
Q2
$1K Buy
195
+187
+2,338% +$959 ﹤0.01% 4118
2021
Q1
$0 Hold
8
﹤0.01% 4575
2020
Q4
$0 Sell
8
-1,600,004
-100% ﹤0.01% 4316
2020
Q3
$9.31M Sell
1,600,012
-300,025
-16% -$1.75M ﹤0.01% 1854
2020
Q2
$13.7M Sell
1,900,037
-277,617
-13% -$2M ﹤0.01% 1698
2020
Q1
$10.2M Sell
2,177,654
-8,714
-0.4% -$40.8K ﹤0.01% 1684
2019
Q4
$17.5M Sell
2,186,368
-768,335
-26% -$6.16M ﹤0.01% 1649
2019
Q3
$20.3M Sell
2,954,703
-105,626
-3% -$727K ﹤0.01% 1565
2019
Q2
$25.4M Sell
3,060,329
-10,767
-0.4% -$89.4K ﹤0.01% 1523
2019
Q1
$30.5M Sell
3,071,096
-1,988,816
-39% -$19.8M ﹤0.01% 1414
2018
Q4
$38.7M Sell
5,059,912
-2,165,001
-30% -$16.6M 0.01% 1252
2018
Q3
$126M Buy
+7,224,913
New +$126M 0.01% 857